妊娠期血小板减少的研究进展
Research Advances in Pregnancy-Related Thrombocytopenia
摘要: 妊娠期血小板减少是产科妊娠期目前第二常见的血液系统疾病，仅次于贫血；血小板减少的病因、发病机制复杂多样、生理与病理性因素交织，且各种病因导致的血小板减少的临床表现相似，使临床上早期准确识别血小板减少的病因具有挑战性。不同病因导致的血小板减少对母婴结局不同，早期准确识别妊娠期血小板减少的病因、并积极给予个体化治疗，从而最大程度改善母婴预后。本文阐述了妊娠期血小板减少的病因、发病机制、早期诊断标志物、不同病因的鉴别及干预策略。
Abstract: Pregnancy with thrombocytopenia (PT) is currently the most common hematological disorder during pregnancy following anemia. The etiology and pathogenesis of thrombocytopenia are complex and diverse, involving an interplay of physiological and pathological factors. Moreover, the clinical manifestations of thrombocytopenia caused by different etiologies are similar, making it challenging to accurately identify the underlying cause of thrombocytopenia in the early stages of clinical diagnosis. The etiology of thrombocytopenia significantly impacts maternal and neonatal outcomes. Early and accurate identification of the underlying cause of thrombocytopenia during pregnancy, coupled with prompt and individualized treatment, is essential for maximizing maternal and neonatal prognosis. This article discusses the etiology, pathogenesis, early diagnostic markers, differential diagnosis of various causes and intervention strategies for thrombocytopenia during pregnancy.
文章引用：张思容, 万晓红. 妊娠期血小板减少的研究进展[J]. 临床个性化医学, 2026, 5(1): 476-484. https://doi.org/10.12677/jcpm.2026.51066

参考文献

[1] 陈晓, 邹红兰, 史娇阳, 等. 妊娠合并血小板减少的病因及围生期管理[J]. 医学综述, 2019, 25(22): 4464-4467+4472.
[2] 李莉平, 应豪. 妊娠期血小板减少的原因与鉴别诊断[J]. 中国实用妇科与产科杂志, 2022, 38(12): 1166-1170.
[3] (2019) ACOG Practice Bulletin No. 207: Thrombocytopenia in Pregnancy. Obstetrics & Gynecology, 133, e181-e193.
[4] Gernsheimer, T., James, A.H. and Stasi, R. (2013) How I Treat Thrombocytopenia in Pregnancy. Blood, 121, 38-47. [Google Scholar] [CrossRef] [PubMed]
[5] Myers, B. (2012) Diagnosis and Management of Maternal Thrombocytopenia in Pregnancy. British Journal of Haematology, 158, 3-15. [Google Scholar] [CrossRef] [PubMed]
[6] Fogerty, A.E. (2018) Thrombocytopenia in Pregnancy: Mechanisms and Management. Transfusion Medicine Reviews, 32, 225-229. [Google Scholar] [CrossRef] [PubMed]
[7] Park, Y.H. (2022) Diagnosis and Management of Thrombocytopenia in Pregnancy. Blood Research, 57, S79-S85. [Google Scholar] [CrossRef] [PubMed]
[8] Reese, J.A., Peck, J.D., Yu, Z., Scordino, T.A., Deschamps, D.R., McIntosh, J.J., et al. (2019) Platelet Sequestration and Consumption in the Placental Intervillous Space Contribute to Lower Platelet Counts during Pregnancy. American Journal of Hematology, 94, E8-E11. [Google Scholar] [CrossRef] [PubMed]
[9] 刘中娜, 蒋荣珍, 滕银成. 妊娠期血小板减少诊疗进展[J]. 医学综述, 2021, 27(4): 685-690+696.
[10] Levine, R.J., Maynard, S.E., Qian, C., Lim, K., England, L.J., Yu, K.F., et al. (2004) Circulating Angiogenic Factors and the Risk of Preeclampsia. New England Journal of Medicine, 350, 672-683. [Google Scholar] [CrossRef] [PubMed]
[11] Verlohren, S., Herraiz, I., Lapaire, O., Schlembach, D., Zeisler, H., Calda, P., et al. (2014) New Gestational Phase-Specific Cutoff Values for the Use of the Soluble FMS-Like Tyrosine Kinase-1/Placental Growth Factor Ratio as a Diagnostic Test for Preeclampsia. Hypertension, 63, 346-352. [Google Scholar] [CrossRef] [PubMed]
[12] Sibai, B.M. (2004) Diagnosis, Controversies, and Management of the Syndrome of Hemolysis, Elevated Liver Enzymes, and Low Platelet Count. Obstetrics & Gynecology, 103, 981-991. [Google Scholar] [CrossRef] [PubMed]
[13] Baxter, J.K. and Weinstein, L. (2004) HELLP Syndrome: The State of the Art. Obstetrical & Gynecological Survey, 59, 838-845. [Google Scholar] [CrossRef] [PubMed]
[14] (2020) Gestational Hypertension and Preeclampsia: ACOG Practice Bulletin, Number 222. Obstetrics & Gynecology, 135, e237-e260.
[15] Petca, A., Miron, B.C., Pacu, I., Dumitrașcu, M.C., Mehedințu, C., Șandru, F., et al. (2022) HELLP Syndrome—Holistic Insight into Pathophysiology. Medicina, 58, Article 326. [Google Scholar] [CrossRef] [PubMed]
[16] Lisonkova, S., Razaz, N., Sabr, Y., Muraca, G., Boutin, A., Mayer, C., et al. (2020) Maternal Risk Factors and Adverse Birth Outcomes Associated with HELLP Syndrome: A Population‐Based Study. BJOG: An International Journal of Obstetrics & Gynaecology, 127, 1189-1198. [Google Scholar] [CrossRef] [PubMed]
[17] Pishko, A.M., Levine, L.D. and Cines, D.B. (2020) Thrombocytopenia in Pregnancy: Diagnosis and Approach to Management. Blood Reviews, 40, Article 100638. [Google Scholar] [CrossRef] [PubMed]
[18] Cavaignac-Vitalis, M., Vidal, F., Simon-Toulza, C., Boulot, P., Guerby, P., Chantalat, E., et al. (2019) Conservative versus Active Management in HELLP Syndrome: Results from a Cohort Study. The Journal of Maternal-Fetal & Neonatal Medicine, 32, 1769-1775. [Google Scholar] [CrossRef] [PubMed]
[19] 黄靖锐, 张卫社. 重症妊娠期急性脂肪肝的管理: 关键指标与多学科协作[J]. 中国实用妇科与产科杂志, 2025, 41(9): 886-890.
[20] Liu, J., Ghaziani, T.T. and Wolf, J.L. (2017) Acute Fatty Liver Disease of Pregnancy: Updates in Pathogenesis, Diagnosis, and Management. American Journal of Gastroenterology, 112, 838-846. [Google Scholar] [CrossRef] [PubMed]
[21] Nelson, D.B., Yost, N.P. and Cunningham, F.G. (2013) Acute Fatty Liver of Pregnancy: Clinical Outcomes and Expected Duration of Recovery. American Journal of Obstetrics and Gynecology, 209, 456.e1-456.e7. [Google Scholar] [CrossRef] [PubMed]
[22] Ramadan, M.K., Khaza’al, J., Cha’ar, D., Bazzi, Z., Bachnak, R. and Haibeh, P. (2021) Second‐Trimester Acute Fatty Liver Disease of Pregnancy: A Brief Review of the Literature and a Case Report. Journal of Obstetrics and Gynaecology Research, 47, 34-43. [Google Scholar] [CrossRef] [PubMed]
[23] Cao, W., Chen, T., Jiang, W., Geng, Y., Xie, B., Wang, Q., et al. (2022) Timely Identification and Successful Treatment of Acute Fatty Liver of Pregnancy without Obvious Clinical Symptoms. Medicine, 101, e28723. [Google Scholar] [CrossRef] [PubMed]
[24] Erez, O., Othman, M., Rabinovich, A., Leron, E., Gotsch, F. and Thachil, J. (2022) DIC in Pregnancy—Pathophysiology, Clinical Characteristics, Diagnostic Scores, and Treatments. Journal of Blood Medicine, 13, 21-44. [Google Scholar] [CrossRef] [PubMed]
[25] 潘惜雨, 孟金玉, 宋坤. 妊娠期急性脂肪肝研究进展[J]. 现代妇产科进展, 2021, 30(3): 227-229+232.
[26] Eslick, R. and McLintock, C. (2020) Managing ITP and Thrombocytopenia in Pregnancy. Platelets, 31, 300-306. [Google Scholar] [CrossRef] [PubMed]
[27] 梅恒, 胡豫. 成人原发免疫性血小板减少症诊断与治疗中国指南(2020年版)解读[J]. 临床内科杂志, 2021, 38(6): 431-432.
[28] Perera, M. and Garrido, T. (2017) Advances in the Pathophysiology of Primary Immune Thrombocytopenia. Hematology, 22, 41-53. [Google Scholar] [CrossRef] [PubMed]
[29] Provan, D. and Semple, J.W. (2022) Recent Advances in the Mechanisms and Treatment of Immune Thrombocytopenia. eBioMedicine, 76, Article 103820. [Google Scholar] [CrossRef] [PubMed]
[30] Iraqi, M., Perdomo, J., Yan, F., Choi, P.Y.-. and Chong, B.H. (2015) Immune Thrombocytopenia: Antiplatelet Autoantibodies Inhibit Proplatelet Formation by Megakaryocytes and Impair Platelet Production in Vitro. Haematologica, 100, 623-632. [Google Scholar] [CrossRef] [PubMed]
[31] Bauer, M.E., Arendt, K., Beilin, Y., Gernsheimer, T., Perez Botero, J., James, A.H., et al. (2021) The Society for Obstetric Anesthesia and Perinatology Interdisciplinary Consensus Statement on Neuraxial Procedures in Obstetric Patients with Thrombocytopenia. Anesthesia & Analgesia, 132, 1531-1544. [Google Scholar] [CrossRef] [PubMed]
[32] 刘倚君, 刘兴会. 妊娠合并特发性血小板减少性紫癜[J]. 实用妇产科杂志, 2021, 37(8): 578-581.
[33] Provan, D., Arnold, D.M., Bussel, J.B., Chong, B.H., Cooper, N., Gernsheimer, T., et al. (2019) Updated International Consensus Report on the Investigation and Management of Primary Immune Thrombocytopenia. Blood Advances, 3, 3780-3817. [Google Scholar] [CrossRef] [PubMed]
[34] Mingot Castellano, M.E., Pascual Izquierdo, C., González, A., Viejo Llorente, A., Valcarcel Ferreiras, D., Sebastián, E., et al. (2022) Recommendations for the Diagnosis and Treatment of Patients with Thrombotic Thrombocytopenic Purpura. Medicina Clínica (English Edition), 158, 630.e1-630.e14. [Google Scholar] [CrossRef] 
[35] Wendt, R., Völker, L., Bommer, M., Wolf, M., von Auer, C., Kühne, L., et al. (2024) 100 Jahre Thrombotisch-Thrombozytopenische Purpura (TTP)—Was Haben Wir Gelernt? DMW-Deutsche Medizinische Wochenschrift, 149, 1423-1430. [Google Scholar] [CrossRef] [PubMed]
[36] Delmas, Y., Helou, S., Chabanier, P., Ryman, A., Pelluard, F., Carles, D., et al. (2015) Incidence of Obstetrical Thrombotic Thrombocytopenic Purpura in a Retrospective Study within Thrombocytopenic Pregnant Women. A Difficult Diagnosis and a Treatable Disease. BMC Pregnancy and Childbirth, 15, Article No. 137. [Google Scholar] [CrossRef] [PubMed]
[37] Gómez-Seguí, I., Pascual Izquierdo, C., Mingot Castellano, M.E. and de la Rubia Comos, J. (2023) An Update on the Pathogenesis and Diagnosis of Thrombotic Thrombocytopenic Purpura. Expert Review of Hematology, 16, 17-32. [Google Scholar] [CrossRef] [PubMed]
[38] Pourrat, O., Coudroy, R. and Pierre, F. (2015) Differentiation between Severe HELLP Syndrome and Thrombotic Microangiopathy, Thrombotic Thrombocytopenic Purpura and Other Imitators. European Journal of Obstetrics & Gynecology and Reproductive Biology, 189, 68-72. [Google Scholar] [CrossRef] [PubMed]
[39] Bonnez, Q., Sakai, K. and Vanhoorelbeke, K. (2023) ADAMTS13 and Non-Adamts13 Biomarkers in Immune-Mediated Thrombotic Thrombocytopenic Purpura. Journal of Clinical Medicine, 12, 6169. [Google Scholar] [CrossRef] [PubMed]
[40] Scully, M., Thomas, M., Underwood, M., Watson, H., Langley, K., Camilleri, R.S., et al. (2014) Thrombotic Thrombocytopenic Purpura and Pregnancy: Presentation, Management, and Subsequent Pregnancy Outcomes. Blood, 124, 211-219. [Google Scholar] [CrossRef] [PubMed]
[41] Sakai, K., Fujimura, Y., Nagata, Y., Higasa, S., Moriyama, M., Isonishi, A., et al. (2020) Success and Limitations of Plasma Treatment in Pregnant Women with Congenital Thrombotic Thrombocytopenic Purpura. Journal of Thrombosis and Haemostasis, 18, 2929-2941. [Google Scholar] [CrossRef] [PubMed]
[42] 杨晓雨, 王传孝, 徐岩, 等. 血栓性微血管病的发病机制及诊治进展[J]. 临床肾脏病杂志, 2025, 25(4): 344-351.
[43] Yan, K., Desai, K., Gullapalli, L., Druyts, E. and Balijepalli, C. (2020) Epidemiology of Atypical Hemolytic Uremic Syndrome: A Systematic Literature Review. Clinical Epidemiology, 12, 295-305. [Google Scholar] [CrossRef] [PubMed]
[44] Kaufeld, J.K., Kühne, L., Schönermarck, U., Bräsen, J.H., von Kaisenberg, C., Beck, B.B., et al. (2024) Features of Postpartum Hemorrhage-Associated Thrombotic Microangiopathy and Role of Short-Term Complement Inhibition. Kidney International Reports®, 9, 919-928. [Google Scholar] [CrossRef] [PubMed]
[45] Bruel, A., Kavanagh, D., Noris, M., Delmas, Y., Wong, E.K.S., Bresin, E., et al. (2017) Hemolytic Uremic Syndrome in Pregnancy and Postpartum. Clinical Journal of the American Society of Nephrology, 12, 1237-1247. [Google Scholar] [CrossRef] [PubMed]
[46] Lee, H., Kang, E., Kang, H.G., Kim, Y.H., Kim, J.S., Kim, H., et al. (2020) Consensus Regarding Diagnosis and Management of Atypical Hemolytic Uremic Syndrome. The Korean Journal of Internal Medicine, 35, 25-40. [Google Scholar] [CrossRef] [PubMed]
[47] Ferreira, F.L.B., Colella, M.P., Medina, S.S., Costa-Lima, C., Fiusa, M.M.L., Costa, L.N.G., et al. (2017) Evaluation of the Immature Platelet Fraction Contribute to the Differential Diagnosis of Hereditary, Immune and Other Acquired Thrombocytopenias. Scientific Reports, 7, Article No. 3355. [Google Scholar] [CrossRef] [PubMed]
[48] Sachdev, R., Tiwari, A., Goel, S., Raina, V. and Sethi, M. (2014) Establishing Biological Reference Intervals for Novel Platelet Parameters (Immature Platelet Fraction, High Immature Platelet Fraction, Platelet Distribution Width, Platelet Large Cell Ratio, Platelet-X, Plateletcrit, and Platelet Distribution Width) and Their Correlations among Each Other. Indian Journal of Pathology and Microbiology, 57, 231-235. [Google Scholar] [CrossRef] [PubMed]
[49] Chuansumrit, A., Apiwattanakul, N., Sirachainan, N., Paisooksantivatana, K., Athipongarporn, A., Tangbubpha, N., et al. (2020) The Use of Immature Platelet Fraction to Predict Time to Platelet Recovery in Patients with Dengue Infection. Paediatrics and International Child Health, 40, 124-128. [Google Scholar] [CrossRef] [PubMed]
[50] El-Gamal, R.A., Mekawy, M.A., Abd Elkader, A.M., Abdelbary, H.M. and Fayek, M.Z. (2020) Combined Immature Platelet Fraction and Schistocyte Count to Differentiate Pregnancy-Associated Thrombotic Thrombocytopenic Purpura from Severe Preeclampsia/Haemolysis, Elevated Liver Enzymes, and Low Platelet Syndrome (SPE/HELLP). Indian Journal of Hematology and Blood Transfusion, 36, 316-323. [Google Scholar] [CrossRef] [PubMed]
[51] Goel, G., Semwal, S., Khare, A., Joshi, D., Amerneni, C.K., Pakhare, A., et al. (2021) Immature Platelet Fraction: Its Clinical Utility in Thrombocytopenia Patients. Journal of Laboratory Physicians, 13, 214-218. [Google Scholar] [CrossRef] [PubMed]